Neal JM et al., 2018-02: U.S. professional-society practice advisory on local anesthetic systemic toxicity. Only the title and abstract could be opened; intravenous lipid emulsion appears in the abstract as the rescue therapy. Methylene blue is not part of the advisory and is reserved for methemoglobinemia.
The Third American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local Anesthetic Systemic Toxicity: Executive Summary 2017
Title page
Neal JM et al., 2018-02: U.S. professional-society practice advisory on local anesthetic systemic toxicity. Only the title and abstract could be opened; intravenous lipid emulsion appears in the abstract as the rescue therapy. Methylene blue is not part of the advisory and is reserved for methemoglobinemia. Practice advisory (expert consensus), not a trial. The full text was behind a paywall; only the title and abstract were opened. Methylene blue is not part of the LAST treatment algorithm; it is reserved for methemoglobinemia. The excerpt is the article title, used as a record field. Also filed as MTB-46 (claims C9, F4). Study type: review.
